| CAS登录号 | 中文名 | 英文名 | 分子结构式 | 分子式 | 详情 | 供应商 |
| 271241-14-6 | 四氟甲醚菊酯; 2,2-二甲基-3-(2-甲基-1-丙烯基)环丙烷羧酸2,3,5,6-四氟-4-(甲氧基甲基)苄酯 | Dimefluthrin; [2,3,5,6-Tetrafluoro-4-(methoxymethyl)phenyl]methyl 2,2-dimethyl-3-(2-methyl-1-propenyl)cyclopropanecarboxylate |  | C19H22F4O3 | 详情 | 供应商 |
| 436097-28-8 | (3,3-二甲氧基-1-丙炔基)环丙烷 | (3,3-Dimethoxy-prop-1-ynyl)-cyclopropane |  | C8H12O2 | 详情 | 供应商 |
| 380336-99-2 | 4-甲酰基-2-甲氧基苯基环丙烷碳酸酯 | Cyclopropanecarboxylicacid, 4-formyl-2-methoxyphenyl ester; 4-FORMYL-2-METHOXYPHENYL CYCLOPROPANECARBOXYLATE; AKOS BBS-00006523; AKOS B014275; ART-CHEM-BB B014275; CYCLOPROPANECARBOXYLIC ACID 4-FORMYL-2-METHOXY-PHENYL ESTER; 6-(4-Fluorophenyl)imidazo2,1-bü1,3üthiazole-5-carboxaldehyde |  | C12H12O4 | 详情 | 供应商 |
| 849217-64-7 | N-[3-氟-4-[[6-甲氧基-7-[[3-(吗啉-4-基)丙基]氧]喹啉-4-基]氧]苯基]-N'-(4-氟苯基)环丙烷-1,1-二甲酰胺; N- | GSK 1363089; Foretinib; GSK 1363089; EXEL-2880; XL880; N-[3-Fluoro-4-[[6-(methyloxy)-7-[[3-(morpholin-4-yl)propyl]oxy]quinolin-4-yl]oxy]phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide; N-[3-Fluoro-4-[[6-methoxy-7-[3-(4-morpholinyl)propoxy]-4-quinolinyl]oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide; XL880(GSK1363089) | 无 | C34H34F2N4O6 | 详情 | 供应商 |
| 849217-68-1 | CABOZANTINIB; N-[4-[(6,7-二甲氧基-4-喹啉基)氧基]苯基]-N'-(4-氟苯基)-1,1-环丙烷二甲酰胺 | N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide; N-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide; Cabozantinib; N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide; XL184; Cabozantinib(XL184) |  | C28H24FN3O5 | 详情 | 供应商 |
| 1351690-41-9 | 4-(2-甲氧基-1甲基乙氧基)-2-甲基苯甲酸; 4-(2-甲氧基-1甲基乙氧基)-2-甲基苯甲酸; N,N-二甲基-2-苄基-(2S)-1-氮杂环丙烷基磺酰胺 | 4-(1-Methoxypropan-2-yloxy)-2-Methylbenzoic acid; 4-(1-Methoxypropan-2-yloxy)-2-Methylbenzoic acid; (S)-2-Benzyl-N,N-diMethylaziridine-1-sulfonaMide |  | C12H16O4 | 详情 | 供应商 |
| 1140909-48-3 | N-[4-[(6,7-二甲氧基-4-喹啉基)氧基]苯基]-N'-(4-氟苯基)-1,1-环丙烷二甲酰胺 (S)-苹果酸盐; CABOZANTINIB (S)-苹果酸盐; N-[4-[(6,7-二甲氧基-4-喹啉基)氧基]苯基]-N'-(4-氟苯基)-1,1-环丙烷二甲酰胺 (S)-苹果酸盐; CABOZANTINIB MALATE; 卡博替尼苹果酸盐; 苹果酸卡博替尼; L-苹果酸卡博替尼 | (2S)-2-Hydroxybutanedioic acid compd. with N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide (1:1); (2S)-2-Hydroxybutanedioic acid compd. with N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide (1:1); Cabozantinib (S)-malate; Cabozantinib L-Malate Salt; N-[4-[(6,7-DiMethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxaMide (2S)-; Cabozantinib (S)-Malate(XL-184); Cabozantinib L-Malate |  | C32H30FN3O10 | 详情 | 供应商 |
sitemap.xml